Skip to content

INMED PHARMACEUTICALS INC.: filings

Every INMED PHARMACEUTICALS INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 23 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2026-09-09fiscal FY 202632640001213900-26-098419
10-Q2026-05-06fiscal Q3 202630900001213900-26-052920
10-Q2026-02-11fiscal Q2 2026371060001213900-26-014996
10-Q2025-11-06fiscal Q1 202637760001213900-25-107152
10-K2025-09-23fiscal FY 202543830001213900-25-090210
10-Q2025-05-12fiscal Q3 2025421200001213900-25-042126
10-Q2025-02-12fiscal Q2 2025421160001213900-25-013063
10-Q2024-11-14fiscal Q1 202542860001213900-24-098445
10-K2024-09-30fiscal FY 202446910001213900-24-082843
10-Q2024-02-13fiscal Q2 2024421150001213900-24-013414
10-Q2023-11-14fiscal Q1 202443850001213900-23-086255
10-K2023-09-29fiscal FY 202345890001213900-23-080842
10-Q2023-05-15fiscal Q3 2023451280001213900-23-039477
10-Q2023-02-17fiscal Q2 2023451280001213900-23-012859
10-Q2022-11-14fiscal Q1 202345870001213900-22-071487
10-K2022-09-23fiscal FY 202247890001213900-22-058355
10-Q2022-05-13fiscal Q3 2022451100001213900-22-026136
10-Q2022-02-14fiscal Q2 2022451100001213900-22-007611
10-Q2021-11-10fiscal Q1 202236710001213900-21-057944
10-K2021-09-24fiscal FY 202138740001213900-21-049679
10-Q2021-05-13fiscal Q3 202138900001213900-21-025892
10-Q2021-02-11fiscal Q2 202138890001213900-21-008271
10-Q2020-12-17fiscal Q1 202136690001213900-20-043142

Inspect the source

Entity
INMED PHARMACEUTICALS INC. / CIK 0001728328
Captured
2026-09-21T17:27:41.396Z
SEC response SHA-256
1f73e76cc8d3847e3658f72033c4ed33ce1de4528067a6f82d159b8aa5c1b91f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001728328.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))